240 related articles for article (PubMed ID: 27858941)
1. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.
Bellazzo A; Di Minin G; Collavin L
Cell Death Differ; 2017 Jan; 24(1):15-25. PubMed ID: 27858941
[TBL] [Abstract][Full Text] [Related]
2. An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications.
De Florian Fania R; Bellazzo A; Collavin L
Cell Death Differ; 2024 Jun; ():. PubMed ID: 38902547
[TBL] [Abstract][Full Text] [Related]
3. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.
Zhang H; Zhang R; Luo Y; D'Alessio A; Pober JS; Min W
J Biol Chem; 2004 Oct; 279(43):44955-65. PubMed ID: 15310755
[TBL] [Abstract][Full Text] [Related]
4. DAB2IP in cancer.
Liu L; Xu C; Hsieh JT; Gong J; Xie D
Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
[TBL] [Abstract][Full Text] [Related]
5. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis.
Xie D; Gore C; Zhou J; Pong RC; Zhang H; Yu L; Vessella RL; Min W; Hsieh JT
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19878-83. PubMed ID: 19903888
[TBL] [Abstract][Full Text] [Related]
6. Smurf1 regulation of DAB2IP controls cell proliferation and migration.
Li X; Dai X; Wan L; Inuzuka H; Sun L; North BJ
Oncotarget; 2016 May; 7(18):26057-69. PubMed ID: 27036023
[TBL] [Abstract][Full Text] [Related]
7. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
[TBL] [Abstract][Full Text] [Related]
8. Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.
Bellazzo A; Di Minin G; Valentino E; Sicari D; Torre D; Marchionni L; Serpi F; Stadler MB; Taverna D; Zuccolotto G; Montagner IM; Rosato A; Tonon F; Zennaro C; Agostinis C; Bulla R; Mano M; Del Sal G; Collavin L
Cell Death Differ; 2018 Jul; 25(7):1224-1238. PubMed ID: 29568059
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of DAB2IP by Akt and SCFFbw7 pathways.
Dai X; North BJ; Inuzuka H
Oncotarget; 2014 May; 5(10):3307-15. PubMed ID: 24912918
[TBL] [Abstract][Full Text] [Related]
10. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
[TBL] [Abstract][Full Text] [Related]
11. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
[TBL] [Abstract][Full Text] [Related]
13. DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.
Yun EJ; Baek ST; Xie D; Tseng SF; Dobin T; Hernandez E; Zhou J; Zhang L; Yang J; Sun H; Xiao G; He D; Kittler R; Hsieh JT
Oncogene; 2015 May; 34(21):2741-52. PubMed ID: 25043300
[TBL] [Abstract][Full Text] [Related]
14. DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer.
Miller AL; Perurena N; Gardner A; Hinoue T; Loi P; Laird PW; Cichowski K
Cancer Res; 2023 Jun; 83(11):1800-1814. PubMed ID: 36939385
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer.
Calvisi DF; Ladu S; Conner EA; Seo D; Hsieh JT; Factor VM; Thorgeirsson SS
J Hepatol; 2011 Feb; 54(2):311-9. PubMed ID: 21067840
[TBL] [Abstract][Full Text] [Related]
16. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
17. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
[TBL] [Abstract][Full Text] [Related]
18. DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer.
Feng S; Huang Q; Deng J; Jia W; Gong J; Xie D; Shen J; Liu L
Cancer Lett; 2022 Apr; 532():215588. PubMed ID: 35150809
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of DAB2IP in chemoresistance of prostate cancer cells.
Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT
Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317
[TBL] [Abstract][Full Text] [Related]
20. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS; Lai CL; Lai CH; Chang KH; Wu K; Tseng SF; Fazli L; Gleave M; Xiao G; Gandee L; Sharifi N; Moro L; Tzai TS; Hsieh JT
Oncotarget; 2014 Aug; 5(15):6425-36. PubMed ID: 25115390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
